Myriad Genetics Restores Most Systems After Unauthorized Access Disrupts Testing Operations

• Myriad Genetics temporarily suspended testing operations and order management systems following unauthorized network access detected on November 2, 2026.
• Most systems have returned to normal operations. The business does not expect a material adverse impact from the incident.
• An investigation is assessing the scope of unauthorized access, including whether patient records were accessed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Myriad Genetics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-070659), on November 05, 2026, and is solely responsible for the information contained therein.